Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis
Clinical trial NCT01216280 · UNKNOWN
Trial details
- NCT number
- NCT01216280
- Sponsor
- Natrogen Therapeutics International, Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-07-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.